Pharming Group N.V.
Develops and commercializes medicines for rare, debilitating, and life-threatening diseases.
PHARM | AS
Overview
Corporate Details
- ISIN(s):
- NL0010391025 (+1 more)
- LEI:
- 724500DCJ9MPG74JEH91
- Country:
- Netherlands
- Address:
- Darwinweg 24, 2333CR Leiden
- Website:
- https://www.pharming.com/
- Sector:
- Manufacturing
Description
Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company develops and commercializes an innovative portfolio of medicines to serve patients with unmet medical needs. Its portfolio includes protein replacement therapies, precision medicines, small molecules, and biologics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2009-03-31 08:07 |
Pharming confirms Rhucin European MAA filing timeline
|
English | 72.7 KB | ||
| 2009-03-26 08:57 |
Pharming shareholders meeting to be held on 15 April 2009
|
English | 68.1 KB | ||
| 2009-02-13 08:48 |
Pharming announces annual results 2008
|
English | 128.6 KB | ||
| 2009-01-19 11:00 |
PHARMING PROVIDES BUSINESS UPDATE
|
English | 82.6 KB | ||
| 2009-01-19 10:37 |
Pharming announces debt reduction of EUR 5 million
|
English | 72.8 KB | ||
| 2008-12-09 08:43 |
PHARMING ANNOUNCES REDUCTION OF € 20 MILLION DEBT AND IMPROVEMENT OF BALANCE SH…
|
English | 72.9 KB | ||
| 2008-12-01 09:11 |
Pharming announces change in composition of Board of Supervisory Directors
|
English | 69.6 KB | ||
| 2008-11-26 14:11 |
PHARMING ANNOUNCES POSITIVE RESULTS FROM PRODARSAN® PHASE I STUDY
|
English | 75.7 KB | ||
| 2008-11-18 14:48 |
PHARMING AND ASLAN GROUP SIGN LICENSE AGREEMENT FOR LACTOFERRIN
|
English | 75.1 KB | ||
| 2008-10-17 08:32 |
Pharming announces third quarter 2008 results
|
English | 110.6 KB | ||
| 2008-10-13 17:24 |
Pharming shareholders appoint Sijmen de Vries as new CEO
|
English | 74.8 KB | ||
| 2008-09-26 08:45 |
Pharming's Board of Supervisory Directors nominates new CEO
|
English | 76.0 KB | ||
| 2008-09-25 10:27 |
Pharming provides Business update at UBS Conference
|
English | 74.8 KB | ||
| 2008-09-18 09:20 |
Pharming to present at UBS Global Life Sciences Conference
|
English | 59.2 KB | ||
| 2008-09-18 09:20 |
Pharming to present at UBS Global Life Sciences Conference
|
English | 60.3 KB |
Automate Your Workflow. Get a real-time feed of all Pharming Group N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharming Group N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharming Group N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-24 | D.A. Jorn | Non-Executive member | Other | 7,446 | N/A |
| 2023-03-21 | P. Sekhri | Non-Executive member | Other | 9,363 | N/A |
| 2022-10-27 | P. Sekhri | Non-Executive member | Buy | 13,013 | 12,232.22 EUR |
| 2022-10-27 | M. Pykett | Non-Executive member | Buy | 9,760 | 9,174.40 EUR |
| 2022-08-04 | P. Sekhri | Non-Executive member | Buy | 13,013 | 10,000.23 EUR |
| 2022-08-04 | S. Baert | Non-Executive member | Buy | 9,760 | 7,500.36 EUR |
| 2022-05-25 | J. van der Meijs | Non-Executive member | Buy | 9,300 | 86,490,000.00 EUR |
| 2022-05-25 | P. Sekhri | Non-Executive member | Buy | 12,398 | 9,527.62 EUR |
| 2022-05-25 | M. Pykett | Non-Executive member | Buy | 9,300 | 7,146.86 EUR |
| 2022-03-24 | S. de Vries | Non-Executive member | Buy | 318,150 | 232,249.50 EUR |
Peer Companies
